Nucleix vs Vessi Medical
Nucleix vs Vessi Medical, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nucleix is on 56/100 and Vessi Medical on 50/100.
Where each one leads
Nucleix
- our overall score: 56/100 against 50/100
- headcount: 74 against 9
- funding raised: $88.0M against $18.2M
- LinkedIn following: 7,846 against 665
Vessi Medical
- agent readiness: 42/100 against 30/100
- domain rating: 45/100 against 38/100
- headcount growth: +162.2% against +7.1%
At a glance
| Measure | Nucleix | Vessi Medical |
|---|---|---|
| What it is | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. | Israeli startup developing surface cryotherapy for non-muscle-invasive bladder cancer. |
| Category | Healthcare, Lung, Bladder, Cancer | Healthcare, Cancer, Bladder, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Hardware |
| Founded | 2008 | 2015 |
| Headquarters | Rehovot, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Nucleix | Vessi Medical |
|---|---|---|
| Employees | 74 | 9 |
| Headcount growthLast 12 months | +7.1% | +162.2% |
| Total funding | $88.0M | $18.2M |
| Latest round | Funding Round | Series A |
| LinkedIn followers | 7,846 | 665 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nucleix | Vessi Medical |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 50/100 |
| Traction | 59/100 | 46/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 36/100 | 28/100 |
| Quality | 55/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 45/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nucleix | Vessi Medical |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4 |
What users say
| Measure | Nucleix | Vessi Medical |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
Nucleix vs Vessi Medical: common questions
Which is better, Nucleix or Vessi Medical?
On our 0-100 score Nucleix rates higher (56/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Nucleix and Vessi Medical compare on the numbers?
Nucleix leads on our overall score (56/100 against 50/100), headcount (74 against 9), funding raised ($88.0M against $18.2M), LinkedIn following (7,846 against 665). Vessi Medical leads on agent readiness (42/100 against 30/100), domain rating (45/100 against 38/100), headcount growth (+162.2% against +7.1%).
What do real users say about Nucleix and Vessi Medical?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full Nucleix review and pricing or the Vessi Medical review and pricing. You can also browse other Nucleix alternatives we track.